drugset / Trial / NCT05324618

Tacrolimus Versus Hydrocortisone in Atopic Dermatitis

NCT05324618

RandomizedParallel-groupDouble-blindTreatment

Summary

Atopic dermatitis (AD) is a very common inflammatory, genetic skin disorder that occurs more frequently in children. Its exact etiology is not known but it is characterized by pruritic skin reactions with elevation in the levels of inflammatory markers. Corticosteroids are the first line and the mainstay therapy in management of atopic dermatitis but have many local and systemic adverse effects. The study aims to evaluate the efficacy and safety of topical tacrolimus ointment in comparison to topical hydrocortisone cream in management of children diagnosed with atopic dermatitis.

Timeline

Start
2022-05-15
Primary completion
2022-11-20
Completion
2023-04-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 1 % Topical
Comparator Tacrolimus Small molecule 0.03 % Topical

Indications